Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report

2022 ◽  
Author(s):  
Jose Nativi-Nicolau ◽  
Josef Stehlik ◽  
Aaron J. Kelkhoff ◽  
Brian Khong ◽  
Crystal M. Truax ◽  
...  
Keyword(s):  
Case Report ◽  
Transplant Recipient ◽  
Metastatic Melanoma ◽  
Heart Transplant ◽  
Allograft Rejection ◽  
Heart Transplant Recipient ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Allograft Vasculopathy

scholarly journals Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients

PLoS ONE ◽  
2014 ◽  
Vol 9 (12) ◽  
pp. e113260 ◽  
Author(s):  
Carlos A. Labarrere ◽  
John R. Woods ◽  
James W. Hardin ◽  
Beate R. Jaeger ◽  
Marian Zembala ◽  
...  
Keyword(s):  
Heart Transplant ◽  
Inflammatory Markers ◽  
Cardiac Allograft Vasculopathy ◽  
Cardiac Allograft ◽  
Transplant Recipients ◽  
Allograft Vasculopathy ◽  
Heart Transplant Recipients
Sign in / Sign up

Export Citation Format

Share Document